Join
Live feed
·
INSIDERFilingvia Quantisnow
Kymera Therapeutics Inc. logo

Chief Operating Officer Chadwick Jeremy G was granted 12,575 shares and sold $515,594 worth of shares (5,958 units at $86.54), increasing direct ownership by 10% to 73,810 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYMR (Kymera Therapeutics Inc.) and more on Quantisnow.